Short % of Float (as of May 29, 2015)3: 27.30%
Friday, July 10, 2015 two weeks from today. News released on or before that deadline. I figure up $0.50 to $0.75 a share to occur on one particular day in the near term.
June 23, 2015 11:05 AM EDT by Lilah Olsher in Exclusively Published • Healthcare • Insights
Vical Incorporated shares are tumbling 42.85% to $0.81 after the company reported disappointing top-line data from its Phase 1/2 HSV-2 vaccine program. In response, analysts from H.C. Wainwright and Roth Capital offered opposing insights on the stock.
Wainwright analyst Mark Breidenbach came out with a research report today, reiterating a Buy rating on the stock with a $2.50 price target, which represents a potential upside of 231% from where the stock is currently trading.
Breidenbach noted, “Although we are not currently ascribing value to the HSV program, we retain cautious optimism that a planned nine-month analysis could show a benefit in clinically meaningful endpoints including reduction in genital lesions and recurrence rates. In our opinion, Vical’s partnered CMV vaccine program, which addresses a serious unmet need in immunosuppressed transplant patients, remains the primary value driver for the company. With a newly licensed anti-fungal asset, a big pharma partner in Astellas, and a pro forma cash position of approximately $42.7M (which we estimate could fund operations into 2017), we believe Vical remains an attractive player with potential upside for long-term, risk-tolerant investors.”
Article is a Google Finance.
Item 1.02 Termination of a Material Definitive Agreement.
On June 15, 2015, Local Corporation (the “Registrant”) received a notice of termination effective November 1, 2015 from Yahoo! Inc. and Yahoo! EMEA Limited (as successor in interest to Yahoo! SARL and together with Yahoo! Inc., “Yahoo”) with respect to that certain Yahoo! Publisher Network contract #1-26652287, dated as of November 1, 2012, as amended. The Agreement provides for the distribution of Yahoo’s paid search results by Registrant for which the Registrant is compensated a certain percentage of the adjusted gross revenue (as defined in the Agreement) derived by Yahoo from such paid search results. The effective date of the Agreement is November 1, 2012 and was scheduled to end on October 31, 2017, subject to the earlier termination by either party on the second, third and fourth anniversaries of the Agreement upon sixty (60) days advance written notice. Yahoo has elected to terminate on the third anniversary pursuant to this notice of termination. The Agreement represented a material source of revenue for the Registrant, including 43% and 46% of the Registrant’s total revenue in 2014 and 2013, respectively.
Could get to the recent $1.25 price target or a bit lower like $1.20. Short of BK, the share price could easily double or 100% return sometime in the summer. Been through years of trading oil company stocks a 100% with this equity could occur in one week.
1. Click your name in the upper right hand quarter.
2. Sign out and sign in.
3. Use another alias ID that you have.
4. Click New Topic several times.
5. Post a message that says TEST, as that usually signals to the spybot server to stop the Horse Manure.